Suppr超能文献

氨氯地平敏感型钠氢交换体中跨膜组氨酸的突变分析

Mutational analysis of transmembrane histidines in the amiloride-sensitive Na+/H+ exchanger.

作者信息

Wang D, Balkovetz D F, Warnock D G

机构信息

Department of Medicine, University of Alabama at Birmingham, USA.

出版信息

Am J Physiol. 1995 Aug;269(2 Pt 1):C392-402. doi: 10.1152/ajpcell.1995.269.2.C392.

Abstract

The histidine-reactive reagent, diethyl pyrocarbonate (DEPC) inhibits the human amiloride-sensitive Na+/H+ exchanger (NHE1) in stably transfected fibroblasts. NHE1 was protected by cimetidine and amiloride from DEPC, and DEPC inhibition was reversed with hydroxylamine, suggesting a role for critical histidine groups in NHE activity. We replaced the histidines (H) in putative transmembrane domains (H35, H120, H349) with glycine (G) using site-directed mutagenesis. There was no significant change in NHE activity of the H120G; H349G; H120,349G; and H35,120,349G mutants compared with wild type. The 50% inhibition concentration values for amiloride, ethyl isopropyl amiloride (EIPA), and cimetidine of the H349G mutant were significantly increased compared with the wild-type NHE1. We also examined the DEPC effect on the transport activity of the triple histidine mutant (H35,120,349G) and found that NHE1 activity was still inhibited by DEPC with reversal by hydroxylamine and protected by amiloride and cimetidine. Kinetic analysis of DEPC inhibition indicated that two "critical" histidine residues are required for NHE transport activity. Substitutions of H349 with asparagine (N), glutamine (Q), serine (S), tyrosine (Y), valine (V), leucine (L), and phenylalanine (F) were also examined. There were no changes in NHE activity of these mutants compared with wild type. The H349G and H349L mutants became more resistant to amiloride, whereas the H349Y and H349F mutants became more sensitive to amiloride. The H349S (mimics NHE3) and H349Y (mimics NHE4) mutations had only modest effects on amiloride sensitivity. These results indicate that H349 affects the interaction of NHE1 with its inhibitors, even though substitutions at this site, per se, do not appear to explain the differences in amiloride sensitivity between different NHE isoforms. Despite clear-cut effects of the H349G mutation on the competitive interaction of NHE1 with cimetidine and EIPA, this mutation did not affect the affinity of NHE1 for its cationic substrates (Na+, Li+).

摘要

组氨酸反应试剂焦碳酸二乙酯(DEPC)可抑制稳定转染的成纤维细胞中的人阿米洛利敏感型Na⁺/H⁺交换体(NHE1)。西咪替丁和阿米洛利可保护NHE1免受DEPC的影响,且DEPC的抑制作用可被羟胺逆转,这表明关键组氨酸基团在NHE活性中发挥作用。我们使用定点诱变技术将假定跨膜结构域中的组氨酸(H)(H35、H120、H349)替换为甘氨酸(G)。与野生型相比,H120G、H349G、H120,349G和H35,120,349G突变体的NHE活性没有显著变化。与野生型NHE1相比,H349G突变体对阿米洛利、乙基异丙基阿米洛利(EIPA)和西咪替丁的50%抑制浓度值显著增加。我们还研究了DEPC对三重组氨酸突变体(H35,120,349G)转运活性的影响,发现NHE1活性仍被DEPC抑制,可被羟胺逆转,并受阿米洛利和西咪替丁保护。DEPC抑制的动力学分析表明,NHE转运活性需要两个“关键”组氨酸残基。我们还研究了用天冬酰胺(N)、谷氨酰胺(Q)、丝氨酸(S)、酪氨酸(Y)、缬氨酸(V)、亮氨酸(L)和苯丙氨酸(F)替换H349的情况。与野生型相比,这些突变体的NHE活性没有变化。H349G和H349L突变体对阿米洛利的抗性增强,而H349Y和H349F突变体对阿米洛利更敏感。H349S(模拟NHE3)和H349Y(模拟NHE4)突变对阿米洛利敏感性的影响较小。这些结果表明,H349影响NHE1与其抑制剂的相互作用,尽管该位点的替换本身似乎并不能解释不同NHE亚型之间阿米洛利敏感性的差异。尽管H349G突变对NHE1与西咪替丁和EIPA的竞争性相互作用有明显影响,但该突变并不影响NHE1对其阳离子底物(Na⁺、Li⁺)的亲和力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验